Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Bacterial Infections and Mycoses

  Free Subscription

Articles published in Diagn Microbiol Infect Dis

Retrieve available abstracts of 209 articles:
HTML format

Single Articles

    July 2022
  1. BRIDWELL MR, Bajaj S, Gress TW, Hambuchen MD, et al
    Impact of MRSA polymerase chain reaction (PCR) wound swabs on antibiotic de-escalation in skin and soft tissue infections.
    Diagn Microbiol Infect Dis. 2022;103:115722.
    PubMed     Abstract available

  2. ANNE-GAELLE R, Celia S, Jeanne C, Frederic B, et al
    Performances of the BD MAX CDIFF assay for the detection of toxigenic Clostridioides difficile using Cary-Blair preserved samples.
    Diagn Microbiol Infect Dis. 2022;103:115701.
    PubMed     Abstract available

  3. YOO IY, Shin DP, Heo W, Ha SI, et al
    Comparison of BD MAX Check-Points CPO assay with Cepheid Xpert Carba-R assay for the detection of carbapenemase-producing Enterobacteriaceae directly from rectal swabs.
    Diagn Microbiol Infect Dis. 2022;103:115716.
    PubMed     Abstract available

    June 2022
  4. KOBAYASHI Y, Shibata S, Yagi T
    Molecular epidemiology and antimicrobial susceptibility profiles of Campylobacter jejuni isolated from bloodstream infections and enteritis in Japan.
    Diagn Microbiol Infect Dis. 2022;103:115681.
    PubMed     Abstract available

    May 2022
  5. CLOSE RM, Sutcliffe CG, Galdun P, Reid A, et al
    Point-of-care molecular diagnostics for the detection of group A Streptococcus in non-invasive skin and soft tissue infections: a validation study.
    Diagn Microbiol Infect Dis. 2022;103:115729.
    PubMed     Abstract available

  6. YAMADA T, Minami K, Oda K, Suzuki K, et al
    Probability of target attainment of oral antimicrobials for Escherichia coli and Klebsiella pneumoniae based on Monte Carlo simulations.
    Diagn Microbiol Infect Dis. 2022;103:115662.
    PubMed     Abstract available

  7. KHODER M, Rafei R, Osman M, Kassem II, et al
    Emergence of a Neisseria flavescens clinical strain with a high level of third-generation cephalosporins resistance in Lebanon.
    Diagn Microbiol Infect Dis. 2022;103:115660.
    PubMed     Abstract available

  8. ZHU X, Zhao Y, Zhu C, Wang Y, et al
    Rapid detection of cagA-positive Helicobacter pylori based on duplex recombinase aided amplification combined with lateral flow dipstick assay.
    Diagn Microbiol Infect Dis. 2022;103:115661.
    PubMed     Abstract available

  9. PIETIKAINEN A, Backman I, Henningsson AJ, Hytonen J, et al
    Clinical performance and analytical accuracy of a C6 peptide-based point-of-care lateral flow immunoassay in Lyme borreliosis serology.
    Diagn Microbiol Infect Dis. 2022;103:115657.
    PubMed     Abstract available

    April 2022
  10. DIENSTHUBER D, Simnacher U, Peters S, Walther P, et al
    Clearing Chlamydia abortus infection in epithelial cells and primary human macrophages by use of antibiotics and the MDM2-p53-inhibitor nutlin-3.
    Diagn Microbiol Infect Dis. 2022;103:115715.
    PubMed     Abstract available

  11. AONO A, Murase Y, Chikamatsu K, Igarashi Y, et al
    In vitro activity of tedizolid and linezolid against multidrug-resistant Mycobacterium tuberculosis: a comparative study using microdilution broth assay and genomics.
    Diagn Microbiol Infect Dis. 2022;103:115714.
    PubMed     Abstract available

  12. ROSTAMIAN M, Kooti S, Mohammadi B, Salimi Y, et al
    A systematic review and meta-analysis of Listeria monocytogenes isolated from human and non-human sources: the antibiotic susceptibility aspect.
    Diagn Microbiol Infect Dis. 2022;102:115634.
    PubMed     Abstract available

  13. YOSHIMURA M, Tokushige C, Maruyama JI, Kawano Y, et al
    Emerging resistance to beta-lactams in Pantoea ananatis isolated from an immunocompetent patient with bacteremia.
    Diagn Microbiol Infect Dis. 2022;102:115633.
    PubMed     Abstract available

  14. PRINCE HE, Batterman HJ, Realegeno SE, Marlowe EM, et al
    Transience of interference in an immunoassay measuring serum levels of beta-D-glucan.
    Diagn Microbiol Infect Dis. 2022;102:115630.
    PubMed     Abstract available

  15. PFALLER MA, Carvalhaes CG, DeVries S, Huband MD, et al
    Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017-2019.
    Diagn Microbiol Infect Dis. 2022;102:115627.
    PubMed     Abstract available

    March 2022
  16. SAVINOVA T, Bocharova Y, Mayanskiy N, Chebotar I, et al
    Genetic determinants of virulence and antibiotic resistance are common for Pseudomonas aeruginosa ST235 isolates from cystic fibrosis patients from various geographical regions.
    Diagn Microbiol Infect Dis. 2022;102:115596.
    PubMed     Abstract available

    February 2022
  17. BOSCHIERO MN, Duarte A, Palamim CVC, Alvarez AE, et al
    Frequency of respiratory pathogens other than SARS-CoV-2 detected during COVID-19 testing.
    Diagn Microbiol Infect Dis. 2022;102:115576.
    PubMed     Abstract available

  18. SUN Y, Shukla MR, Deutsch J, Cao W, et al
    Evaluation of the effect of extended refrigerated storage of serum and plasma specimens on syphilis serologic test results.
    Diagn Microbiol Infect Dis. 2022;102:115588.
    PubMed     Abstract available

  19. MELENDEZ JH, Chen FE, Wang TH
    Antimicrobial susceptibility testing of Neisseria gonorrhoeae using a phenotypic-molecular assay and lyophilized antimicrobials.
    Diagn Microbiol Infect Dis. 2022;102:115590.
    PubMed     Abstract available

  20. ROSSATO L, Arantes JP, Ribeiro SM, Simionatto S, et al
    Antibacterial activity of gallium nitrate against polymyxin-resistant Klebsiella pneumoniae strains.
    Diagn Microbiol Infect Dis. 2022;102:115569.
    PubMed     Abstract available

    January 2022
  21. BOLKER A, Coe K, Smith J, Stevenson K, et al
    Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients.
    Diagn Microbiol Infect Dis. 2022;102:115558.
    PubMed     Abstract available

  22. SADER HS, Mendes RE, Streit JM, Carvalhaes CG, et al
    Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020).
    Diagn Microbiol Infect Dis. 2022;102:115557.
    PubMed     Abstract available

    A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease.
    Diagn Microbiol Infect Dis. 2022;102:115572.
    PubMed     Abstract available

    December 2021
  24. MEEX C, Devey A, Defeche J, Bontems S, et al
    Evaluation of the Revogene(R) GBS DS assay performance for the intrapartum screening of group B streptococcus in comparison with intrapartum culture.
    Diagn Microbiol Infect Dis. 2021;102:115616.
    PubMed     Abstract available

  25. DE BENEDETTO I, Boglione L
    Reply to: impact of Chronic Hepatitis C virus co-infection on outcomes of infective endocarditis in people who inject drugs.
    Diagn Microbiol Infect Dis. 2021;102:115615.

  26. CHOI H, Hwang M, Chatterjee P, Jinadatha C, et al
    Rare Lelliottia nimipressuralis from a wound infection case report using whole genome sequencing-based bacterial identification.
    Diagn Microbiol Infect Dis. 2021;101:115538.
    PubMed     Abstract available

  27. HU S, Lv Z, Wang Y, Shen J, et al
    Novel Quadruplex PCR for detecting and genotyping mobile colistin resistance genes in human samples.
    Diagn Microbiol Infect Dis. 2021;101:115419.
    PubMed     Abstract available

  28. BUTCHER M, Puiu D, Romagnoli M, Carroll KC, et al
    Rapidly fatal infection with Bacillus cereus/thuringiensis: genome assembly of the responsible pathogen and consideration of possibly contributing toxins.
    Diagn Microbiol Infect Dis. 2021;101:115534.
    PubMed     Abstract available

  29. WOODSON EN, Katz SS, Mosley SS, Danavall DC, et al
    Use of real-time PCR as an alternative to conventional genotyping methods for the laboratory detection of lymphogranuloma venereum (LGV).
    Diagn Microbiol Infect Dis. 2021;101:115532.
    PubMed     Abstract available

  30. BOUSSI LS, Popli T, Feola N, Nog R, et al
    Clinical and microbiological characteristics of patients with bacteremia and normal procalcitonin.
    Diagn Microbiol Infect Dis. 2021;101:115515.
    PubMed     Abstract available

  31. SADEK M, Poirel L, Dominguez Pino M, D'Emidio F, et al
    Evaluation of SuperCAZ/AVI(R) Medium for Screening Ceftazidime-avibactam Resistant Gram-negative Isolates.
    Diagn Microbiol Infect Dis. 2021;101:115475.
    PubMed     Abstract available

  32. SCANGARELLA-OMAN NE, Dixon P, Koeth LM, DiFranco-Fisher J, et al
    Analysis of antimicrobial susceptibility testing methods and variables and in vitro activity of gepotidacin against urogenital Neisseria gonorrhoeae in men.
    Diagn Microbiol Infect Dis. 2021;101:115484.
    PubMed     Abstract available

  33. SENCHYNA F, Tamburini FB, Murugesan K, Watz N, et al
    Comparative genomics of Enterobacter cloacae complex before and after acquired clinical resistance to Ceftazidime-Avibactam.
    Diagn Microbiol Infect Dis. 2021;101:115511.
    PubMed     Abstract available

  34. HOVAN MR, Narayanan N, Cedarbaum V, Bhowmick T, et al
    Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia.
    Diagn Microbiol Infect Dis. 2021;101:115505.
    PubMed     Abstract available

  35. AKAPELWA ML, Kapalamula TF, Ouchi-Aizu Y, Hang'ombe BM, et al
    Evaluation of IS1245 LAMP in Mycobacterium avium and the influence of host-related genetic diversity on its application.
    Diagn Microbiol Infect Dis. 2021;101:115494.
    PubMed     Abstract available

    November 2021
  36. HEIREMAN L, Bruynseels P, Camps K, Geysels D, et al
    Comparison of the QuantiFERON-TB(R) Gold Plus on LIAISON(R) XL and T-SPOT.TB for the diagnosis of latent Mycobacterium tuberculosis infection in a low tuberculosis incidence population.
    Diagn Microbiol Infect Dis. 2021;102:115613.
    PubMed     Abstract available

  37. LOPEZ-PINTOR JM, Martinez-Garcia L, Maruri A, Menendez B, et al
    Quantification of plasmid copy number as surrogate marker of virulence among different invasive and non-invasive genotypes of Chlamydia trachomatis.
    Diagn Microbiol Infect Dis. 2021;102:115610.
    PubMed     Abstract available

  38. MCCREERY R, Nielsen L, Clarey D, Murphy C, et al
    Evaluation of cerebrospinal fluid white blood cell count criteria for use of the BioFire(R) FilmArray(R) Meningitis/Encephalitis Panel in immunocompromised and nonimmunocompromised patients.
    Diagn Microbiol Infect Dis. 2021;102:115605.
    PubMed     Abstract available

  39. JIANG X, Zhu L, Zhan D
    Development of a recombinase polymerase amplification assay for rapid detection of Streptococcus suis type 2 in nasopharyngeal swab samples.
    Diagn Microbiol Infect Dis. 2021;102:115594.
    PubMed     Abstract available

  40. ZAMORA-CINTAS MI, Lopez DJ, Blanco AC, Rodriguez TM, et al
    Coinfections among hospitalized patients with covid-19 in the first pandemic wave.
    Diagn Microbiol Infect Dis. 2021;101:115416.
    PubMed     Abstract available

  41. NOVY E, Goury A, Thivilier C, Guillard T, et al
    Algorithm for rational use of Film Array Pneumonia Panel in bacterial coinfections of critically ill ventilated COVID-19 patients.
    Diagn Microbiol Infect Dis. 2021;101:115507.
    PubMed     Abstract available

  42. RUIZ-BASTIAN M, Falces-Romero I, Ramos-Ramos JC, de Pablos M, et al
    Bacterial co-infections in COVID-19 pneumonia in a tertiary care hospital: Surfing the first wave.
    Diagn Microbiol Infect Dis. 2021;101:115477.
    PubMed     Abstract available

  43. TIMBROOK TT, Hueth KD, Ginocchio CC
    Identification of bacterial co-detections in COVID-19 critically Ill patients by BioFire(R) FilmArray(R) pneumonia panel: a systematic review and meta-analysis.
    Diagn Microbiol Infect Dis. 2021;101:115476.
    PubMed     Abstract available

  44. UGABAN KB, She RC
    The clinical significance of staphylococcus pettenkoferi: a retrospective review at a tertiary care medical center.
    Diagn Microbiol Infect Dis. 2021;102:115592.
    PubMed     Abstract available

  45. YONETANI S, Hirao C, Ohnishi H
    Background of patients with Aerococcus spp. detected in blood cultures, and drug sensitivity of Aerococcus spp.
    Diagn Microbiol Infect Dis. 2021;101:115506.
    PubMed     Abstract available

  46. DIEZ A, Carrano G, Bregon-Villahoz M, Cuetara MS, et al
    Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients.
    Diagn Microbiol Infect Dis. 2021;101:115509.
    PubMed     Abstract available

  47. RUSSELLO G, Moramarco A, Vizzini L, Farina C, et al
    Diagnostic approach and epidemiology of Microbial Keratitis: findings from an Italian Tertiary Care center.
    Diagn Microbiol Infect Dis. 2021;101:115470.
    PubMed     Abstract available

  48. PFALLER MA, Carvalhaes CG, Messer SA, Rhomberg PR, et al
    In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
    Diagn Microbiol Infect Dis. 2021;101:115473.
    PubMed     Abstract available

  49. VALIATTI TB, Santos FF, Nunes PHS, Cayo R, et al
    Characterization of virulent Klebsiella variicola recovered from inpatients with intestinal and extraintestinal infections between 1987 and 1999.
    Diagn Microbiol Infect Dis. 2021;101:115482.

  50. PHILLIPS TR, Tabesh M, Fairley CK, Maddaford K, et al
    A comparison of cotton-tipped and nylon flocked swabs for culture of Neisseria gonorrhoeae from oropharyngeal samples.
    Diagn Microbiol Infect Dis. 2021;101:115455.
    PubMed     Abstract available

  51. LIN BB, Pattle N, Kelley P, Jaksic AS, et al
    Multiplex RT-PCR provides improved diagnosis of skin and nail dermatophyte infections compared to microscopy and culture: a laboratory study and review of the literature.
    Diagn Microbiol Infect Dis. 2021;101:115413.
    PubMed     Abstract available

    October 2021
  52. MORRISON AR, Jones MC, Makowski CT, Samuel LP, et al
    Evaluation of the selection of cerebrospinal fluid testing in suspected meningitis and encephalitis.
    Diagn Microbiol Infect Dis. 2021;102:115571.
    PubMed     Abstract available

  53. QUIRINO A, Marascio N, Peronace C, Gallo L, et al
    Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes.
    Diagn Microbiol Infect Dis. 2021;101:115485.
    PubMed     Abstract available

  54. JOSHI P, Shrivastava R, Bhagwat S, Patel M, et al
    Activity of beta-lactam plus beta-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
    Diagn Microbiol Infect Dis. 2021;101:115481.
    PubMed     Abstract available

  55. MALCZYNSKI M, Zhu A, Zembower T, Qi C, et al
    Diagnostic performance of Ion 16S metagenomics kit and Ion reporter metagenomics workflow for bacterial pathogen detection in culture-negative clinical specimens from sterile sources.
    Diagn Microbiol Infect Dis. 2021;101:115451.
    PubMed     Abstract available

  56. JOHNSTON MM, Huang V, Hall ST, Buckley MS, et al
    Optimizing outcomes using vancomycin therapeutic drug monitoring in patients with MRSA bacteremia: trough concentrations or area under the curve?
    Diagn Microbiol Infect Dis. 2021;101:115442.
    PubMed     Abstract available

  57. GOLDEN AR, Fear T, Baxter M, Adam HJ, et al
    Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011-2018.
    Diagn Microbiol Infect Dis. 2021;101:115447.
    PubMed     Abstract available

  58. PARMELAND L, Bourru T, Kyungu V, Rousseau N, et al
    A rapid and inexpensive protocol to screen for third generation cephalosporin-resistant and non-fermenting Gram-negative rods directly in positive blood cultures.
    Diagn Microbiol Infect Dis. 2021;101:115428.
    PubMed     Abstract available

  59. NOVAL M, Heil EL, Williams P, Johnson JK, et al
    The potential impact of discrepancies between automated susceptibility platforms and other testing metho`dologies for cefazolin in the treatment of Enterobacterales bloodstream infections.
    Diagn Microbiol Infect Dis. 2021;101:115483.
    PubMed     Abstract available

  60. WORMSER GP, Strle F, Shapiro ED, Auwaerter PG, et al
    Comparison of the clinical practice guidelines for Lyme disease from the Infectious Diseases Society of America: 2000, 2006, and 2020.
    Diagn Microbiol Infect Dis. 2021;101:115446.

  61. CLEMMONS AB, Young HN, Bland CM, Jackson B, et al
    Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremia.
    Diagn Microbiol Infect Dis. 2021;101:115444.
    PubMed     Abstract available

    September 2021
  62. HIYAMA Y, Sato T, Takahashi S, Yamamoto S, et al
    Reduction of susceptibility to azoles and 5-fluorocytosine and growth acceleration in Candida albicans in glucosuria.
    Diagn Microbiol Infect Dis. 2021;102:115556.
    PubMed     Abstract available

  63. GARCIA-CABALLERO A, de Dios Caballero J, Maruri A, Serrano-Tomas MI, et al
    Evaluation of different phenotypic methods to detect methicillin resistance in Staphylococcus aureus isolates recovered from cystic fibrosis patients.
    Diagn Microbiol Infect Dis. 2021;102:115559.
    PubMed     Abstract available

  64. XIA XJ, Zhong Y, Sang B, Li QP, et al
    Violet colonies of Talaromyces marneffei produce on CHROMagar candida medium.
    Diagn Microbiol Infect Dis. 2021;101:115533.
    PubMed     Abstract available

  65. KUFEL WD, Mastro KA, Steele JM, Wang D, et al
    Impact of a pharmacist-facilitated, evidence-based bundle initiative on Staphylococcus aureus bacteremia management.
    Diagn Microbiol Infect Dis. 2021;101:115535.
    PubMed     Abstract available

  66. ROSALES-REYES R, Esposito F, Fontana H, Lezana-Fernandez JL, et al
    Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection.
    Diagn Microbiol Infect Dis. 2021;101:115454.
    PubMed     Abstract available

  67. ITO A, Ishida T, Tachibana H, Nakanishi Y, et al
    Predictors and usefulness of targeted therapy for pneumococcal community-acquired pneumonia diagnosed by the urinary antigen test: a prospective, observational cohort study.
    Diagn Microbiol Infect Dis. 2021;101:115457.
    PubMed     Abstract available

  68. VAN DEN MUNCKHOF EHA, van Sitter RL, Lamont RF, le Cessie S, et al
    Developing an algorithm for the diagnosis of abnormal vaginal discharge in a dutch clinical setting: a pilot study.
    Diagn Microbiol Infect Dis. 2021;101:115431.
    PubMed     Abstract available

    Documentation of a false positive Lyme disease serologic test in a patient with untreated Babesia microti infection carries implications for accurately determining the frequency of Lyme disease coinfections.
    Diagn Microbiol Infect Dis. 2021;101:115429.
    PubMed     Abstract available

  70. MAHAJAN N, Sood S, Das BK, Kapil A, et al
    Molecular characterization of decreased susceptibility to ceftriaxone and genotyping of Neisseria gonorrheae isolates in New Delhi, India.
    Diagn Microbiol Infect Dis. 2021;101:115423.
    PubMed     Abstract available

  71. TICKLER IA, Shettima SA, Dela Cruz CM, Le VM, et al
    Characterization of carbapenem-resistant gram-negative bacterial isolates from Nigeria by whole genome sequencing.
    Diagn Microbiol Infect Dis. 2021;101:115422.
    PubMed     Abstract available

  72. WALKTY A, Karlowsky JA, Baxter MR, Adam HJ, et al
    In vitro activity of imipenem-relebactam against various resistance phenotypes/genotypes of Enterobacterales and Pseudomonas aeruginosa isolated from patients across Canada as part of the CANWARD study, 2016-2019.
    Diagn Microbiol Infect Dis. 2021;101:115418.
    PubMed     Abstract available

  73. KRISTOF K, Adamkova V, Adler A, Gospodarek-Komkowska E, et al
    In vitro activity of ceftazidime-avibactam and comparators against Enterobacterales and Pseudomonas aeruginosa isolates from Central Europe and Israel, 2014-2017 and 2018.
    Diagn Microbiol Infect Dis. 2021;101:115420.
    PubMed     Abstract available

  74. SONG J, Kim S, Park J, Park Y, et al
    Comparison of two beta-D-glucan assays for detecting invasive fungal diseases in immunocompromised patients.
    Diagn Microbiol Infect Dis. 2021;101:115415.
    PubMed     Abstract available

    August 2021
  75. ZHANG CY, Zhang HH, Zhao SL, Wu HY, et al
    Clinical value of alkaline phosphatase on the surface membrane of neutrophils for prediction of bacteremia in patients with systemic inflammatory response syndrome.
    Diagn Microbiol Infect Dis. 2021;100:114105.
    PubMed     Abstract available

  76. BIBBOLINO G, Di Lella FM, Oliva A, Lichtner M, et al
    Molecular epidemiology of NDM-5-producing Escherichia coli high-risk clones identified in two Italian hospitals in 2017-2019.
    Diagn Microbiol Infect Dis. 2021;100:115399.
    PubMed     Abstract available

  77. CLAY TB, Orwig KW, Stevens RA, Davis EP, et al
    Correlation of MRSA polymerase chain reaction (PCR) wound swab testing and wound cultures in skin and soft tissue infections.
    Diagn Microbiol Infect Dis. 2021;100:115389.
    PubMed     Abstract available

    July 2021
  78. LORENZ A, Sobhanie MME, Orzel L, Coe K, et al
    Clinical outcomes of combination versus monotherapy for gram negative non-HACEK infective endocarditis.
    Diagn Microbiol Infect Dis. 2021;101:115504.
    PubMed     Abstract available

  79. MORSLI M, Faltot M, Astier H, Le Dault E, et al
    Real-time next-generation sequencing on shell-vial culture to contribute to diagnosis of lymphatic tuberculosis: a case report.
    Diagn Microbiol Infect Dis. 2021;101:115492.
    PubMed     Abstract available

  80. JENSEN CS, Dargis R, Shewmaker P, Nielsen XC, et al
    Identification of Streptococcus pseudopneumoniae and other mitis group streptococci using matrix assisted laser desorption/ionization - time of flight mass spectrometry.
    Diagn Microbiol Infect Dis. 2021;101:115487.
    PubMed     Abstract available

  81. DANAVALL DC, Gwyn S, Anyalechi GE, Bowden KE, et al
    Assessment and utility of 2 Chlamydia trachomatis Pgp3 serological assays for seroprevalence studies among women in the United States.
    Diagn Microbiol Infect Dis. 2021;101:115480.
    PubMed     Abstract available

  82. GRITTE AS, Morneau KM, Frei CR, Cadena-Zuluaga JA, et al
    Clinical impact of implementation of rapid diagnostic testing of blood cultures with Staphylococcus aureus on patient outcomes.
    Diagn Microbiol Infect Dis. 2021;101:115474.
    PubMed     Abstract available

  83. WORMSER GP, Warshafsky S, Visintainer P
    Postexposure prophylaxis with single-dose doxycycline is effective for prevention of Lyme disease in both the United States and Europe and is also effective for prevention of syphilis and tick-borne relapsing fever.
    Diagn Microbiol Infect Dis. 2021;100:115367.

  84. GUNASEGAR S, Neela VK
    Evaluation of diagnostic accuracy of loop-mediated isothermal amplification method (LAMP) compared with polymerase chain reaction (PCR) for Leptospira spp. in clinical samples: a systematic review and meta-analysis.
    Diagn Microbiol Infect Dis. 2021;100:115369.
    PubMed     Abstract available

  85. FARFOUR E, Si Larbi AG, Cattoir V, Corvec S, et al
    Temocillin susceptibility among Enterobacterales strains recovered from blood culture in France.
    Diagn Microbiol Infect Dis. 2021;100:115368.
    PubMed     Abstract available

  86. EL KHADIR M, Boukhris SA, Zahir SO, Benajah DA, et al
    CagE, cagA and cagA 3' region polymorphism of Helicobacter pylori and their association with the intra-gastric diseases in Moroccan population.
    Diagn Microbiol Infect Dis. 2021;100:115372.
    PubMed     Abstract available

  87. GULLSBY K, Lindh L, Adriaenssens R, Herrmann B, et al
    Comparison of three real-time PCR methods for detection of macrolide-resistant Mycoplasma genitalium in Sweden.
    Diagn Microbiol Infect Dis. 2021;100:115349.
    PubMed     Abstract available

  88. WORMSER GP, McKenna D, Shaffer KD, Silverman JH, et al
    Evaluation of selected variables to determine if any had predictive value for, or correlated with, residual symptoms at approximately 12 months after diagnosis and treatment of early Lyme disease.
    Diagn Microbiol Infect Dis. 2021;100:115348.
    PubMed     Abstract available

  89. SAPOZHNIKOV J, Huang A, Zeeck K, Gibble A, et al
    Comparison of outcomes in urinary tract infections caused by AmpC-harboring organisms treated with AmpC stable versus AmpC susceptible agents.
    Diagn Microbiol Infect Dis. 2021;101:115472.
    PubMed     Abstract available

    June 2021
  90. HUANG DB, Sader HS, Rhomberg PR, Gaukel E, et al
    Anti-staphylococcal lysin, LSVT-1701, activity: In vitro susceptibility of Staphylococcus aureus and coagulase-negative staphylococci (CoNS) clinical isolates from around the world collected from 2002 to 2019.
    Diagn Microbiol Infect Dis. 2021;101:115471.
    PubMed     Abstract available

  91. TOM C, Huang G, Kovalic AJ, Davis KA, et al
    Impact of Chronic Hepatitis C virus co-infection on outcomes of infective endocarditis in people who inject drugs.
    Diagn Microbiol Infect Dis. 2021;101:115453.
    PubMed     Abstract available

  92. CAMERON DJ, Maloney EL
    Aggregating data does not strengthen the support for using a single dose of doxycycline as postexposure prophylaxis for a blacklegged tick bite.
    Diagn Microbiol Infect Dis. 2021;100:115345.

  93. YAMAIRI K, Yamada K, Imoto W, Kuwabara G, et al
    Risk factor analysis for piperacillin-tazobactam-resistant Enterobacter spp. bacteremia at a tertiary hospital.
    Diagn Microbiol Infect Dis. 2021;100:115342.
    PubMed     Abstract available

  94. ZACHARIOUDAKIS IM, Zervou FN, Phillips MS, Aguero-Rosenfeld ME, et al
    Rate and consequences of missed Clostridioides (Clostridium) difficile infection diagnosis from nonreporting of Clostridioides difficile results of the multiplex GI PCR panel: experience from two-hospitals.
    Diagn Microbiol Infect Dis. 2021;100:115346.
    PubMed     Abstract available

  95. GENTRY CA, Williams RJ 2nd, Campbell D
    Continued decline in the prevalence of the Clostridioides difficile BI/NAP1/027 strain across the United States Veterans Health Administration.
    Diagn Microbiol Infect Dis. 2021;100:115308.
    PubMed     Abstract available

  96. KELLY AJ, Ivey ML, Gulvik CA, Humrighouse BW, et al
    A real-time multiplex PCR assay for detection of the causative agents of rat bite fever, Streptobacillus moniliformis and zoonoticStreptobacillus species.
    Diagn Microbiol Infect Dis. 2021;100:115335.
    PubMed     Abstract available

  97. TORRES RT, Fachi MM, Boger B, Marson BM, et al
    Sensitivity and specificity of multibacillary and paucibacillary leprosy laboratory tests: A systematic review and meta-analysis.
    Diagn Microbiol Infect Dis. 2021;100:115337.
    PubMed     Abstract available

    May 2021
  98. OLDBERG K, Rasmussen M
    Enterococcus faecalis in blood cultures-a prospective study on the role of persistent bacteremia.
    Diagn Microbiol Infect Dis. 2021;101:115433.
    PubMed     Abstract available

  99. FOSCHI C, Turello G, Lazzarotto T, Ambretti S, et al
    Performance of PhenoMatrix for the detection of Group B Streptococcus from recto-vaginal swabs.
    Diagn Microbiol Infect Dis. 2021;101:115427.
    PubMed     Abstract available

  100. WANG H, Salamon D, Jean S, Leber AL, et al
    Evaluation of the Cepheid Xpert SA Nasal Complete for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in nasal swabs from pediatric patients.
    Diagn Microbiol Infect Dis. 2021;101:115417.
    PubMed     Abstract available

  101. JOHNSTON BD, Thuras P, Porter SB, Clabots C, et al
    Activity of cefiderocol, ceftazidime-avibactam, and eravacycline against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-20017) in relation to phylogenetic background, sequence type 131 subclones, blaCTX-M genotype,
    Diagn Microbiol Infect Dis. 2021;100:115314.
    PubMed     Abstract available

  102. MITCHELMORE PJ, Withers NJ, Sheldon CD, Scotton CJ, et al
    Culture-independent multilocus sequence typing of Pseudomonas aeruginosa for cross-infection screening.
    Diagn Microbiol Infect Dis. 2021;100:115315.
    PubMed     Abstract available

  103. ANDRADE ESN, Brandao JG, da Silva JS, Kurizky PS, et al
    A systematic review and meta-analysis of studies on the diagnostic accuracy and screening of tests to detect antimicrobial resistance in leprosy.
    Diagn Microbiol Infect Dis. 2021;100:115325.
    PubMed     Abstract available

  104. SHORTRIDGE D, Carvalhaes CG, Streit JM, Flamm RK, et al
    Susceptibility trends of ceftolozane/tazobactam and comparators when tested against U.S. gram-negative bacterial surveillance isolates (2012-2018).
    Diagn Microbiol Infect Dis. 2021;100:115302.
    PubMed     Abstract available

  105. PRINCE HE, Marlowe EM, Schwab DA
    Relationship between DiaSorin Liaison Treponema pallidum antibody indices and confirmatory assay results in the reverse syphilis testing algorithm.
    Diagn Microbiol Infect Dis. 2021;100:115303.
    PubMed     Abstract available

    April 2021
  106. DESHPANDE L, Cantrell L, Romero JR, Carvalhaes C, et al
    Characterization of a vga gene variant recovered from a Staphylococcus saprophyticus causing a community-acquired urinary tract infection: report from the SENTRY Antimicrobial Surveillance Program 2017.
    Diagn Microbiol Infect Dis. 2021;100:115398.
    PubMed     Abstract available

  107. GEORGHIOU SB, Penn-Nicholson A, de Vos M, Mace A, et al
    Analytical performance of the Xpert MTB/XDR(R) assay for tuberculosis and expanded resistance detection.
    Diagn Microbiol Infect Dis. 2021;101:115397.
    PubMed     Abstract available

  108. MICHELSON K, Loffler B, Horing S
    Time to positivity as a prognostic factor in bloodstream infections with Enterococcus spp.
    Diagn Microbiol Infect Dis. 2021;101:115396.
    PubMed     Abstract available

  109. KANYO EC, Nowacki AS, Gordon SM, Shrestha NK, et al
    Comparison of mortality, stroke, and relapse for methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infective endocarditis: a retrospective cohort study.
    Diagn Microbiol Infect Dis. 2021;100:115395.
    PubMed     Abstract available

  110. LU Y, Ma C, Chen R, Hu Z, et al
    Development and validation of a new scoring system for the early diagnosis of tuberculous meningitis in adults.
    Diagn Microbiol Infect Dis. 2021;101:115393.
    PubMed     Abstract available

  111. GOODLET KJ, Tan E, Knutson L, Nailor MD, et al
    Impact of the FilmArray meningitis/encephalitis panel on antimicrobial duration among patients with suspected central nervous system infection.
    Diagn Microbiol Infect Dis. 2021;100:115394.
    PubMed     Abstract available

  112. COTTON S, McHugh MP, Etherson M, Shepherd J, et al
    Evaluation of the molecular detection of ciprofloxacin resistance in Neisseria gonorrhoeae by the ResistancePlus GC assay (SpeeDx).
    Diagn Microbiol Infect Dis. 2021;99:115262.
    PubMed     Abstract available

  113. FARFOUR E, Lomont A, Fihman V, Lecuru M, et al
    Rapid and accurate eXDR screening: use Xpert Carba-R(R) with FecalSwab(R).
    Diagn Microbiol Infect Dis. 2021;99:115279.
    PubMed     Abstract available

  114. WORMSER GP, Warshafsky S, Visintainer P
    Aggregation of data from 4 clinical studies demonstrating efficacy of single-dose doxycycline postexposure for prevention of the spirochetal infections: Lyme disease, syphilis, and tick-borne relapsing fever.
    Diagn Microbiol Infect Dis. 2021;99:115293.
    PubMed     Abstract available

  115. AXENFELD E, Greendyke WG, Li J, Green DA, et al
    Burden and risk factors for inappropriate Clostridioides Difficile infection testing among hospitalized patients.
    Diagn Microbiol Infect Dis. 2021;99:115283.
    PubMed     Abstract available

    March 2021
  116. ZENG HQ, Zhang XB, Cai XY, Yang DY, et al
    Diagnostic value of bronchoalveolar lavage fluid cryptococcal antigen-lateral flow immunochromatographic assay for pulmonary cryptococcosis in non-HIV patients.
    Diagn Microbiol Infect Dis. 2021;99:115276.
    PubMed     Abstract available

  117. HINK RK, Adam HJ, Golden AR, Baxter M, et al
    Comparison of PCV-10 and PCV-13 vaccine coverage for invasive pneumococcal isolates obtained across Canadian geographic regions, SAVE 2011 to 2017.
    Diagn Microbiol Infect Dis. 2021;99:115282.
    PubMed     Abstract available

  118. BABA H, Kanamori H, Kakuta R, Sakurai H, et al
    Genomic characteristics of listeria monocytogenes causing invasive listeriosis in Japan.
    Diagn Microbiol Infect Dis. 2021;99:115233.
    PubMed     Abstract available

  119. SADEK M, Poirel L, Nordmann P
    Rapid detection of carbapenemase-producing Pseudomonas spp. using the NitroSpeed-Carba NP test.
    Diagn Microbiol Infect Dis. 2021;99:115280.
    PubMed     Abstract available

  120. YAO L, Ding Y, Ding M, Yan X, et al
    Characterization of a novel class 1 integron InSW39 and a novel transposon Tn5393k identified in an imipenem-nonsusceptible Salmonella Typhimurium strain in Sichuan, China.
    Diagn Microbiol Infect Dis. 2021;99:115263.
    PubMed     Abstract available

  121. LLOYD CD, Shah-Gandhi B, Parsons BD, Morin SBN, et al
    Direct Clostridioides difficile ribotyping from stool using capillary electrophoresis.
    Diagn Microbiol Infect Dis. 2021;99:115259.
    PubMed     Abstract available

    February 2021
  122. ANINAGYEI E, Ayivor-Djanie R, Attoh J, Dakorah MP, et al
    Molecular detection of Mycobacterium tuberculosis in blood stained sputum samples using GeneXpert PCR assay.
    Diagn Microbiol Infect Dis. 2021;100:115363.
    PubMed     Abstract available

  123. ANGEN O, Johannesen TB, Petersen RF, Uldum SA, et al
    Development of a species-specific real-time PCR test for Chlamydia psittaci and its employment in the investigation of zoonotic transmission from racing pigeons in Denmark.
    Diagn Microbiol Infect Dis. 2021;100:115341.
    PubMed     Abstract available

  124. SONG L, Liang EY, Wang HM, Shen Y, et al
    Differential diagnosis and prospective grading of COVID-19 at the early stage with simple hematological and biochemical variables.
    Diagn Microbiol Infect Dis. 2021;99:115169.
    PubMed     Abstract available

  125. KOW CS, Hasan SS
    Macrolides for patients with COVID-19 and concurrent pertussis infection.
    Diagn Microbiol Infect Dis. 2021;99:115245.

  126. HUJER AM, Hujer KM, Leonard DA, Powers RA, et al
    A comprehensive and contemporary "snapshot" of beta-lactamases in carbapenem resistant Acinetobacter baumannii.
    Diagn Microbiol Infect Dis. 2021;99:115242.
    PubMed     Abstract available

  127. TURBETT SE, Becker M, Desrosiers L, Oliver E, et al
    The effect of transport temperature and time on the recovery of antimicrobial-resistant Enterobacterales in stool.
    Diagn Microbiol Infect Dis. 2021;99:115210.
    PubMed     Abstract available

  128. OKANDA T, Mitsutake H, Aso R, Sekizawa R, et al
    Rapid detection assay of toxigenic Clostridioides difficile through PathOC RightGene, a novel high-speed polymerase chain reaction device.
    Diagn Microbiol Infect Dis. 2021;99:115247.
    PubMed     Abstract available

  129. GOLDSTEIN EJ, Cochrane L, Bone SM, Gunson RN, et al
    Performance characteristics of the SpeeDx PlexPCR VHS assay for the molecular detection of herpes simplex virus, varicella zoster virus, and Treponema pallidum in lesion swabs.
    Diagn Microbiol Infect Dis. 2021;99:115221.
    PubMed     Abstract available

  130. GU Y, Jiang Y, Zhang W, Yu Y, et al
    Risk factors and outcomes of bloodstream infections caused by Acinetobacter baumannii: a case-control study.
    Diagn Microbiol Infect Dis. 2021;99:115229.
    PubMed     Abstract available

  131. NOLAN PJ, Jain R, Cohen L, Finklea JD, et al
    In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
    Diagn Microbiol Infect Dis. 2021;99:115204.
    PubMed     Abstract available

  132. BAIL L, Ito CAS, Arend LNVS, Pilonetto M, et al
    Distribution of genes encoding 16S rRNA methyltransferase in plazomicin-nonsusceptible carbapenemase-producing Enterobacterales in Brazil.
    Diagn Microbiol Infect Dis. 2021;99:115239.
    PubMed     Abstract available

  133. MITTON B, Rule R, Said M
    Laboratory evaluation of the BioFire FilmArray Pneumonia plus panel compared to conventional methods for the identification of bacteria in lower respiratory tract specimens: a prospective cross-sectional study from South Africa.
    Diagn Microbiol Infect Dis. 2021;99:115236.
    PubMed     Abstract available

  134. TANG Y, Yu J, Yang G, Li L, et al
    Probe A shown in the GeneXpert MTB/RIF assay during the detection of Mycobacterium intracellular infections.
    Diagn Microbiol Infect Dis. 2021;99:115243.
    PubMed     Abstract available

  135. SERRANO-COLL H, Salazar-Pelaez LM, Mesa-Betancourt F, Cardona-Castro N, et al
    Oct-6 transcriptional factor a possible biomarker for leprosy diagnosis.
    Diagn Microbiol Infect Dis. 2021;99:115232.
    PubMed     Abstract available

  136. PUZNIAK L, DePestel DD, Yu K, Ye G, et al
    Epidemiology and regional variation of nonsusceptible and multidrug-resistant Pseudomonas aeruginosa isolates from intensive versus non-intensive care units across multiple centers in the United States.
    Diagn Microbiol Infect Dis. 2021;99:115172.
    PubMed     Abstract available

  137. SZABO BG, Duma L, Lenart KS, Kiss R, et al
    Characteristics and predictors of treatment failure with intravenous tigecycline monotherapy among adult patients with severe Clostridioides (Clostridium) difficile infection: a single-centre observational cohort study.
    Diagn Microbiol Infect Dis. 2021;99:115231.
    PubMed     Abstract available

    January 2021
  138. HUANG M, Wang G, Sun Q, Jiang G, et al
    Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in a clinical practice setting of China.
    Diagn Microbiol Infect Dis. 2021;100:115306.
    PubMed     Abstract available

  139. CAMELENA F, Moy AC, Dudoignon E, Poncin T, et al
    Performance of a multiplex polymerase chain reaction panel for identifying bacterial pathogens causing pneumonia in critically ill patients with COVID-19.
    Diagn Microbiol Infect Dis. 2021;99:115183.
    PubMed     Abstract available

  140. BRIGGS N, Campbell S, Gupta S
    Advances in rapid diagnostics for bloodstream infections.
    Diagn Microbiol Infect Dis. 2021;99:115219.
    PubMed     Abstract available

  141. CLARK LT, Beuschel TS, Buss PM, Jameson AP, et al
    Comparison of procalcitonin testing to a targeted audit-and-feedback strategy on prescribed durations of therapy for community-acquired pneumonia.
    Diagn Microbiol Infect Dis. 2021;99:115202.
    PubMed     Abstract available

  142. PENG T, Zong Y, Johnson MD, Menghani SV, et al
    A quantitative enzyme-linked immunoassay (ELISA) to approximate complement-fixing antibody titers in serum from patients with coccidioidomycosis.
    Diagn Microbiol Infect Dis. 2021;99:115198.
    PubMed     Abstract available

  143. CEKIN ZK, Dabos L, Malkocoglu G, Fortineau N, et al
    Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital.
    Diagn Microbiol Infect Dis. 2021;99:115174.
    PubMed     Abstract available

    December 2020
  144. LAYER F, Weber RE, Fleige C, Strommenger B, et al
    Excellent performance of CHROMagar(TM) LIN-R to selectively screen for linezolid-resistant enterococci and staphylococci.
    Diagn Microbiol Infect Dis. 2020;99:115301.
    PubMed     Abstract available

  145. CRISTINACCE A, Wright JG, Macpherson M, Iaconis J, et al
    Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using pharmacokinetic/pharmacodynamic models.
    Diagn Microbiol Infect Dis. 2020;99:115292.
    PubMed     Abstract available

  146. EKE UA, Fairfax MR, Mitchell R, Taylor M, et al
    Staphylococcus pettenkoferi-positive Blood cultures in Hospitalized Patients in a Multi-site Tertiary Center.
    Diagn Microbiol Infect Dis. 2020;99:115284.
    PubMed     Abstract available

  147. HE F, Xia X, Nie D, Yang H, et al
    Respiratory bacterial pathogen spectrum among COVID-19 infected and non-COVID-19 virus infected pneumonia patients.
    Diagn Microbiol Infect Dis. 2020;98:115199.
    PubMed     Abstract available

    November 2020
  148. MWEBE SZ, Yoon C, Asege L, Nakaye M, et al
    Impact of hematocrit on point-of-care C-reactive protein-based tuberculosis screening among people living with HIV initiating antiretroviral therapy in Uganda.
    Diagn Microbiol Infect Dis. 2020;99:115281.
    PubMed     Abstract available

  149. WITTING C, Quaggin-Smith J, Mylvaganam R, Peigh G, et al
    Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report.
    Diagn Microbiol Infect Dis. 2020;99:115272.
    PubMed     Abstract available

  150. WU Z, Wang L, Tan L, Wu J, et al
    Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients.
    Diagn Microbiol Infect Dis. 2020;99:115274.
    PubMed     Abstract available

  151. HAUSER N, Kim JJ, Luethy PM, Schmalzle SA, et al
    Multicenter retrospective cohort study of the clinical significance of Staphylococcus lugdunensis isolated from a single blood culture set.
    Diagn Microbiol Infect Dis. 2020;99:115261.
    PubMed     Abstract available

    October 2020
  152. MUN SJ, Kang JS, Moon C
    Procalcitonin as a predictor of early antibiotic treatment failure in patients with gram-negative bloodstream infections caused by urinary tract infections.
    Diagn Microbiol Infect Dis. 2020;99:115256.
    PubMed     Abstract available

  153. BONDI A, Peradotto M, Bianco G, Ghibaudo D, et al
    Evaluation of BD Phoenix and Microscan WalkAway for determination of fosfomycin susceptibility in Staphylococcus aureus.
    Diagn Microbiol Infect Dis. 2020;99:115240.
    PubMed     Abstract available

  154. LAGATOLLA C, Milic J, Imperi F, Cervoni M, et al
    Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections.
    Diagn Microbiol Infect Dis. 2020;99:115241.
    PubMed     Abstract available

  155. LOPEZ-ROA P, Martin-Higuera C, Ruiz-Serrano MJ, Toro C, et al
    Performance of Xpert MTB/RIF Ultra assay on respiratory and extra-respiratory samples in a high-resource setting with a low tuberculosis prevalence.
    Diagn Microbiol Infect Dis. 2020;99:115235.
    PubMed     Abstract available

  156. CIELO NC, Belmonte T, Raro OHF, da Silva RMC, et al
    Polymyxin B broth disk elution: a feasible and accurate methodology to determine polymyxin B susceptibility in Enterobacterales.
    Diagn Microbiol Infect Dis. 2020;98:115099.
    PubMed     Abstract available

  157. HAGEMANN JB, Furitsch M, Wais V, Bunjes D, et al
    First case of fatal Rhizomucor miehei endocarditis in an immunocompromised patient.
    Diagn Microbiol Infect Dis. 2020;98:115106.
    PubMed     Abstract available

    September 2020
  158. BONNAIRE A, Vernet-Garnier V, Lebrun D, Bajolet O, et al
    Clindamycin combination treatment for the treatment of bone and joint infections caused by clindamycin-susceptible, erythromycin-resistant Staphylococcus spp.
    Diagn Microbiol Infect Dis. 2020;99:115225.
    PubMed     Abstract available

  159. NYBAKKEN EJ, Oppegaard O, Gilhuus M, Jensen CS, et al
    Identification of Streptococcus dysgalactiae using matrix-assisted laser desorption/ionization-time of flight mass spectrometry; refining the database for improved identification.
    Diagn Microbiol Infect Dis. 2020;99:115207.
    PubMed     Abstract available

  160. DYON-TAFANI V, Josse J, Safrani-Lahyani J, Assant-Trouillet S, et al
    Clinical evaluation of three chromogenic media for the isolation of Staphylococcus aureus in respiratory samples in patients with cystic fibrosis.
    Diagn Microbiol Infect Dis. 2020;99:115201.
    PubMed     Abstract available

  161. CASTANHEIRA M, Doyle TB, Carvalhaes CG, Roth BM, et al
    Media for colistin susceptibility testing does not improve the detection of Klebsiella pneumoniae isolates carrying MgrB disruption and other mutation driven colistin resistance mechanisms.
    Diagn Microbiol Infect Dis. 2020;98:115077.
    PubMed     Abstract available

  162. PFALLER MA, Shortridge D, Arends SJR, Duncan LR, et al
    Activity of ceftolozane-tazobactam and comparators when tested against bacterial surveillance isolates collected from patients at risk of infections caused by resistant gram-negative pathogens.
    Diagn Microbiol Infect Dis. 2020;98:115101.
    PubMed     Abstract available

  163. LENHARD JR, Rana AP, Wenzler E, Huang Y, et al
    A coup d'etat by NDM-producing Klebsiella pneumoniae overthrows the major bacterial population during KPC-directed therapy.
    Diagn Microbiol Infect Dis. 2020;98:115080.
    PubMed     Abstract available

  164. LINDSTROM J, Bremell D, Grahn A, Blennow K, et al
    CXCL13 in patients with facial palsy caused by varicella zoster virus and Borrelia burgdorferi: a comparative study.
    Diagn Microbiol Infect Dis. 2020;98:115095.
    PubMed     Abstract available

  165. DEMIRCI-DUARTE S, Unalan-Altintop T, Eser OK, Cakar A, et al
    Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant.
    Diagn Microbiol Infect Dis. 2020;98:115098.
    PubMed     Abstract available

  166. GAWRYS GW, Tun K, Jackson CB, Astorga B, et al
    The impact of rapid diagnostic testing, surveillance software, and clinical pharmacist staffing at a large community hospital in the management of Gram-negative bloodstream infections.
    Diagn Microbiol Infect Dis. 2020;98:115084.
    PubMed     Abstract available

    August 2020
  167. SADER HS, Streit JM, Mendes RE
    Update on the in vitro activity of dalbavancin against indicated species (Staphylococcus aureus, Enterococcus faecalis, beta-hemolytic streptococci, and Streptococcus anginosus group) collected from United States hospitals in 2017-2019.
    Diagn Microbiol Infect Dis. 2020;99:115195.
    PubMed     Abstract available

  168. TICKLER IA, Goering RV, Dewell S, Le VM, et al
    Mobile genetic elements responsible for discordant Staphylococcus aureus phenotypes and genotypes in the same blood culture bottle.
    Diagn Microbiol Infect Dis. 2020;98:115175.
    PubMed     Abstract available

  169. DARBOE KS, Oh TH, Choi SM, Kim HK, et al
    Antimicrobial susceptibility of Staphylococcus species isolated from prosthetic joints with a focus on fluoroquinolone-resistance mechanisms.
    Diagn Microbiol Infect Dis. 2020;99:115173.
    PubMed     Abstract available

  170. GUR D, Hasdemir U, Cakar A, Cavusoglu I, et al
    Comparative in vitro activity of plazomicin and older aminoglyosides against Enterobacterales isolates; prevalence of aminoglycoside modifying enzymes and 16S rRNA methyltransferases.
    Diagn Microbiol Infect Dis. 2020;97:115092.
    PubMed     Abstract available

  171. VEGA AD, Jimenez A, Rosello G, Claeys KC, et al
    Implementing carbapenem-resistance testing algorithms for Enterobacteriales and Pseudomonas aeruginosa: diagnostic and antimicrobial stewardship with timely infection prevention.
    Diagn Microbiol Infect Dis. 2020;97:115069.
    PubMed     Abstract available

  172. PYDEN A, Kang AD, Amato S, Dutta S, et al
    Evaluation of the fully automated AIX1000 rapid plasma reagin system compared to a manual plasma reagin testing method for the diagnosis of syphilis.
    Diagn Microbiol Infect Dis. 2020;97:115081.
    PubMed     Abstract available

  173. EDWARDS T, Williams C, Teethaisong Y, Sealey J, et al
    A highly multiplexed melt-curve assay for detecting the most prevalent carbapenemase, ESBL, and AmpC genes.
    Diagn Microbiol Infect Dis. 2020;97:115076.
    PubMed     Abstract available

  174. RONDINAUD E, Ruppe E, Matheron S, Lucet JC, et al
    Screening methods for intestinal carriage of multidrug-resistant Enterobacterales: interest of enrichment broth.
    Diagn Microbiol Infect Dis. 2020;97:115079.
    PubMed     Abstract available

  175. WORMSER GP, Strle F
    Evaluation of the role of oral penicillin for treating Lyme disease patients with erythema migrans in the United States.
    Diagn Microbiol Infect Dis. 2020;97:115071.
    PubMed     Abstract available

  176. FERNANDEZ-HUERTA M, Salmeron P, Silgado A, Espasa M, et al
    Clinical evaluation of the ResistancePlus MG FleXible test on the GeneXpert Infinity-48s instrument: a near-patient assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance.
    Diagn Microbiol Infect Dis. 2020;97:115062.
    PubMed     Abstract available

    July 2020
  177. OLMEDO M, Alcala L, Valerio M, Marin M, et al
    Three different patterns of positive Clostridium difficile laboratory tests. A comparison of clinical behavior.
    Diagn Microbiol Infect Dis. 2020;97:115050.
    PubMed     Abstract available

  178. MASSERON A, Poirel L, Falgenhauer L, Imirzalioglu C, et al
    Ongoing dissemination of OXA-244 carbapenemase-producing Escherichia coli in Switzerland and their detection.
    Diagn Microbiol Infect Dis. 2020;97:115059.
    PubMed     Abstract available

  179. JOHNSTON BD, Thuras PD, Johnson JR
    Activity of ceftazidime-avibactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
    Diagn Microbiol Infect Dis. 2020;97:115034.
    PubMed     Abstract available

  180. LEROY AG, Persyn E, Guillouzouic A, Ruffier d'Epenoux L, et al
    Catheter-related bloodstream infection due to Tsukamurella pulmonis identified by MALDI-TOF spectrometry, 16S rRNA gene sequencing, and secA1 gene sequencing in an immunocompromised child: a case report and literature review.
    Diagn Microbiol Infect Dis. 2020;97:115052.
    PubMed     Abstract available

    June 2020
  181. WADSKIER F, Cowman K, Szymczak WA, Weston G, et al
    Diagnostic stewardship of Clostridioides difficile polymerase chain reaction results from syndromic diarrhea panel and implications for patient outcomes.
    Diagn Microbiol Infect Dis. 2020;97:115032.
    PubMed     Abstract available

  182. MARBJERG LH, Holzknecht BJ, Dargis R, Dessau RB, et al
    Commercial bacterial and fungal broad-range PCR (Micro-Dx) used on culture-negative specimens from normally sterile sites: diagnostic value and implications for antimicrobial treatment.
    Diagn Microbiol Infect Dis. 2020;97:115028.
    PubMed     Abstract available

  183. WANG C, Bai Y, Li R, Shen C, et al
    Use of Monte Carlo simulation to optimize antibiotic selection for bloodstream infections caused by Enterobacteriaceae in Shandong Province, China.
    Diagn Microbiol Infect Dis. 2020;97:115039.
    PubMed     Abstract available

  184. DONDERS GG, Grinceviciene S, Ruban K, Bellen G, et al
    Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC).
    Diagn Microbiol Infect Dis. 2020;97:115024.
    PubMed     Abstract available

  185. HOFFMANN C, Guillerm G, Le Pape P, Carausu L, et al
    Mucorales DNA detection in serum specimens for early diagnosis of mucormycosis.
    Diagn Microbiol Infect Dis. 2020;97:115004.
    PubMed     Abstract available

  186. PFALLER MA, Carvalhaes CG, Smith CJ, Diekema DJ, et al
    Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012-2017).
    Diagn Microbiol Infect Dis. 2020;97:115016.
    PubMed     Abstract available

  187. KIM SY, Seo J, Shin J, Chung YJ, et al
    Clonal spreading of NDM-5 carbapenemase-producing Escherichia coli isolates in a hospital in South Korea.
    Diagn Microbiol Infect Dis. 2020;97:115027.

  188. BEYAN C, Beyan E
    Mean platelet volume may not be a risk factor for focal involvement in patients with brucellosis.
    Diagn Microbiol Infect Dis. 2020;97:115036.

    May 2020
  189. PALANI GS, Ghafur A, Krishnan P, Rayvathy B, et al
    Intestinal carriage of colistin resistant Enterobacteriaceae in hospitalized patients from an Indian center.
    Diagn Microbiol Infect Dis. 2020;97:114998.
    PubMed     Abstract available

  190. JIA B, Lovari R, Miller H, Metzgar D, et al
    Evaluation of a PCR-electrospray ionization mass spectrometry platform for detection and identification of fungal pathogens directly from prospectively collected bronchoalveolar lavage specimens.
    Diagn Microbiol Infect Dis. 2020;97:114988.
    PubMed     Abstract available

  191. PASTICCI MB, Bozza S, De Socio GV, Frias-Mazuecos A, et al
    Improving the etiological diagnosis of osteoarticular infections with the commercial multiplex real-time polymerase chain reaction SeptiFast(R).
    Diagn Microbiol Infect Dis. 2020;97:115002.
    PubMed     Abstract available

  192. FIDA M, Cunningham SA, Murphy MP, Bonomo RA, et al
    Core genome MLST and resistome analysis of Klebsiella pneumoniae using a clinically amenable workflow.
    Diagn Microbiol Infect Dis. 2020;97:114996.
    PubMed     Abstract available

  193. RAMANATHAN A, Gordon SM, Shrestha NK
    A case series of patients with Gemella endocarditis.
    Diagn Microbiol Infect Dis. 2020;97:115009.
    PubMed     Abstract available

  194. HUANG DB, Charrier C, Hawser S
    Worldwide surveillance of Iclaprim activity: In Vitro susceptibility of gram-positive pathogens collected from patients with skin and skin structure infections from 2013 to 2017.
    Diagn Microbiol Infect Dis. 2020;97:115013.
    PubMed     Abstract available

  195. MESSER SA, Carvalhaes CG, Castanheira M, Pfaller MA, et al
    In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017-2018.
    Diagn Microbiol Infect Dis. 2020;97:115007.
    PubMed     Abstract available

  196. GOLDEN AR, Adam HJ, Baxter M, Walkty A, et al
    In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units.
    Diagn Microbiol Infect Dis. 2020;97:115012.
    PubMed     Abstract available

  197. KOIRALA J, Tyagi I, Guntupalli L, Koirala S, et al
    OXA-23 and OXA-40 producing carbapenem-resistant Acinetobacter baumannii in Central Illinois.
    Diagn Microbiol Infect Dis. 2020;97:114999.
    PubMed     Abstract available

  198. DEMIRDAL T, Sen P
    Risk factors for focal involvement in brucellosis.
    Diagn Microbiol Infect Dis. 2020;97:115003.
    PubMed     Abstract available

    April 2020
  199. KARLOWSKY JA, Kazmierczak KM, Young K, Motyl MR, et al
    In vitro activity of ceftolozane/tazobactam against phenotypically defined extended-spectrum beta-lactamase (ESBL)-positive isolates of Escherichia coli and Klebsiella pneumoniae isolated from hospitalized patients (SMART 2016).
    Diagn Microbiol Infect Dis. 2020;96:114925.
    PubMed     Abstract available

  200. BOYANOVA L, Markovska R, Medeiros J, Gergova G, et al
    Delafloxacin against Helicobacter pylori, a potential option for improving eradication success?
    Diagn Microbiol Infect Dis. 2020;96:114980.
    PubMed     Abstract available

  201. DUTHIE MS, Roferos FO, Abellana JF, Taborada T, et al
    Utility and limitations of serodiagnostic tests in monitoring the response to treatment of leprosy patients.
    Diagn Microbiol Infect Dis. 2020;96:114984.
    PubMed     Abstract available

    March 2020
  202. JEAN S, Lainhart W, Anderson NW, Yarbrough ML, et al
    Clinical impact of molecular identification of rare yeasts and nonsporulating molds recovered in culture from clinical specimens.
    Diagn Microbiol Infect Dis. 2020;96:114945.
    PubMed     Abstract available

  203. SADER HS, Flamm RK, Carvalhaes CG, Castanheira M, et al
    Comparison of ceftazidime-avibactam and ceftolozane-tazobactam in vitro activities when tested against gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2017-2018).
    Diagn Microbiol Infect Dis. 2020;96:114833.
    PubMed     Abstract available

  204. PICCIRILLI A, Perilli M, Piccirilli V, Segatore B, et al
    Molecular characterization of carbapenem-resistant Klebsiella pneumoniae ST14 and ST512 causing bloodstream infections in ICU and surgery wards of a tertiary university hospital of Verona (northern Italy): co-production of KPC-3, OXA-48, and CTX-M-15
    Diagn Microbiol Infect Dis. 2020;96:114968.
    PubMed     Abstract available

  205. ENDO Y, Araoka H, Baba M, Okada C, et al
    Matrix-assisted laser desorption ionization-time of flight mass spectrometry can be used to identify Helicobacter cinaedi.
    Diagn Microbiol Infect Dis. 2020;96:114964.
    PubMed     Abstract available

  206. BANKOWSKI M, Blanton J, Fiorella P, Motes J, et al
    Aureimonas altamirensis masquerading as Brucella spp. in a blood culture from a 68-year-old male with cancer.
    Diagn Microbiol Infect Dis. 2020;96:114957.
    PubMed     Abstract available

  207. WALKTY A, Karlowsky JA, Baxter MR, Adam HJ, et al
    Fosfomycin resistance mediated by fos genes remains rare among extended-spectrum beta-lactamase-producing Escherichia coli clinical isolates recovered from the urine of patients evaluated at Canadian hospitals (CANWARD, 2007-2017).
    Diagn Microbiol Infect Dis. 2020;96:114962.
    PubMed     Abstract available

  208. CALDERARO A, Buttrini M, Martinelli M, Covan S, et al
    Rapid microbial identification and phenotypic antimicrobial susceptibility testing directly from positive blood cultures: a new platform compared to routine laboratory methods.
    Diagn Microbiol Infect Dis. 2020;96:114955.
    PubMed     Abstract available

  209. PRUKSAPHON K, Intaramat A, Ratanabanangkoon K, Nosanchuk JD, et al
    Diagnostic laboratory immunology for talaromycosis (penicilliosis): review from the bench-top techniques to the point-of-care testing.
    Diagn Microbiol Infect Dis. 2020;96:114959.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.